Search Results - "Rezai, Keyvan"

Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.

Authors: Astorgues-Xerri, Lucile Vázquez, Ramiro Odore, Elodie et al.

Source: Leukemia & Lymphoma. Dec2019, Vol. 60 Issue 12, p3067-3070. 4p.

Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.

Authors: Acramel, Alexandre Fouque, Julien Blondeel-Gomes, Sandy et al.

Source: Annals of Work Exposures & Health. Nov2022, Vol. 66 Issue 9, p1215-1223. 9p.

Subjects: Hospitals, Professional practice, Environmental monitoring, Scientific observation, Blood vessels, Liquid chromatography, Medical equipment contamination, Occupational exposure, Antineoplastic agents, Intravenous therapy equipment, Risk assessment, Cyclophosphamide, Mass spectrometry, Descriptive statistics, Automation, Drug adulteration, Collection & preservation of biological specimens, Sterilization (Disinfection), Dosage forms of drugs, Personnel management, Medical equipment

Geographic Terms: France

Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies.

Authors: Kurzrock, Razelle Goel, Sanjay Wheler, Jennifer et al.

Source: Cancer (0008543X). Dec2012, Vol. 118 Issue 24, p6144-6151. 8p.

Regulatory mechanisms of B cell responses and the implication in B cell-related diseases.

Authors: Tsai, Dong-Yan Hung, Kuo-Hsuan Chang, Chia-Wei et al.

Source: Journal of Biomedical Science. 9/1/2019, Vol. 26 Issue 1, pN.PAG-N.PAG. 1p. 2 Diagrams, 2 Charts.

A single-dose PK study of onapristone including the effect of food on absorption.

Authors: Rezai K Chassard D Denot C et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2015 Jul; Vol. 76 (1), pp. 171-7. Date of Electronic Publication: 2015 May 26.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE